Kieren Marr
Kieren Marr, MD, MBA is an Adjunct Professor of medicine and oncology at the Johns Hopkins University School of Medicine. Dr. Marr, a member of the Johns Hopkins Kimmel Cancer Center, trained at Hahnemann University, Duke University and the University of Washington / Fred Hutchinson Cancer Research Center, where she was on faculty for 15 years prior to relocation to Johns Hopkins in 2008. She was the medical director of the JHU Transplant and Oncology Infectious Diseases program and Vice Chair of Medicine for Innovation in Healthcare Implementation until 2022, when she retired from her full – time academic appointment. Dr. Marr is a member of several national and international professional organizations, has authored over 300 peer-reviewed publications, has edited two books in the area of infectious diseases involving immunosuppressed hosts, and is an Associate Editor of Principles and Practices of Infectious Diseases. She is an elected member of the honorary medical societies, the Association of American Physicians (AAP) and the American Society for Clinical Investigators (ASCI), where she served on council and President (2015-2019), and is a Fellow of Infectious Diseases Society of America (IDSA). She is known worldwide for her translational and clinical research focused on diagnostics and treatment of invasive fungal infections.
Financial relationships
-
Attribution:SelfType of financial relationship:There are no financial relationships to disclose.Ineligible company:MycoMed TechnologiesTopic:fungal diagnosticsDate added:Date updated:05/01/2022
-
Attribution:SelfType of financial relationship:There are no financial relationships to disclose.Ineligible company:CidaraTopic:AntifungalsDate added:Date updated:05/01/2022
-
Attribution:SelfType of financial relationship:There are no financial relationships to disclose.Ineligible company:SfungaTopic:AntifungalsDate added:Date updated:05/01/2022